• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用纵向临床体重指数对儿童肥胖进行分类及其验证。

Classification of childhood obesity using longitudinal clinical body mass index and its validation.

作者信息

Ebrahim Nia, Khadegi Apruva, Deng Shuliang, Qian Kun, Yao Zonghui, Thaker Shaleen, May Benjamin, Patibandala Nandan, Lopez-Pintado Sara, Thaker Vidhu V

机构信息

Institute of Human Nutrition, Columbia University, New York, NY, 10032, USA.

Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, 10032, USA.

出版信息

Int J Obes (Lond). 2025 Jul 17. doi: 10.1038/s41366-025-01836-z.

DOI:10.1038/s41366-025-01836-z
PMID:40670646
Abstract

OBJECTIVE

Persistence of childhood adiposity is known to be associated with long-term adverse cardiometabolic risks. Yet, cross-sectional body mass index (BMI) is often used to classify obesity in clinical care and research. This study aimed to develop and validate a childhood BMI classification system using real life longitudinal clinical data.

METHODS

This observational study used electronic health record data from a tertiary care hospital, with replication in an independent cohort. For individuals with ≥ 3 BMI measurements, the median BMI percentile and persistence in the obesity class were used for longitudinal classification. The association between longitudinal BMI class and early onset obesity, socioeconomic status (SES), and adverse cardiometabolic risk was analyzed.

RESULTS

Height, weight, and cardiometabolic risk measures were obtained for 22,352 children from 2014-18 in the primary cohort and 24,444 children in the replication cohort. Obesity (BMI ≥ 95 percentile [BMI]) was observed in 24.1% and severe obesity (BMI ≥ 120% of BMI) in 10.6%. Individuals with early onset obesity (age ≤ 6 years) remained in the same or higher obesity class; those in the high-SES group had lower odds of obesity. The proportion of individuals with cardiometabolic risk increased with obesity severity (p-value 0.01 - < 0.001). The AUC for cardiometabolic risk by longitudinal BMI class was higher compared to that for cross-sectional BMI (80.0% vs. 75.8%, p < 0.001).

CONCLUSIONS

The Longitudinal BMI classification may better reflect long-term cardiometabolic risk in children. This classification can be useful for focused intervention strategies and for profiling of individuals for genetic testing.

摘要

目的

已知儿童肥胖的持续存在与长期不良心脏代谢风险相关。然而,在临床护理和研究中,横断面体重指数(BMI)常被用于肥胖分类。本研究旨在利用真实生活中的纵向临床数据开发并验证一种儿童BMI分类系统。

方法

这项观察性研究使用了一家三级医疗医院的电子健康记录数据,并在一个独立队列中进行了重复验证。对于有≥3次BMI测量值的个体,使用BMI百分位数中位数和肥胖类别中的持续性进行纵向分类。分析了纵向BMI类别与早发性肥胖、社会经济地位(SES)和不良心脏代谢风险之间的关联。

结果

在主要队列中,2014 - 2018年期间为22352名儿童获取了身高、体重和心脏代谢风险指标,在重复队列中为24444名儿童获取了相关指标。观察到肥胖(BMI≥第95百分位数[BMI])的发生率为24.1%,重度肥胖(BMI≥BMI的120%)的发生率为10.6%。早发性肥胖(年龄≤6岁)的个体仍处于相同或更高的肥胖类别;高SES组的个体肥胖几率较低。心脏代谢风险个体的比例随肥胖严重程度增加(p值为0.01 - <0.001)。纵向BMI类别预测心脏代谢风险的曲线下面积(AUC)高于横断面BMI(80.0%对75.8%,p<0.001)。

结论

纵向BMI分类可能更好地反映儿童的长期心脏代谢风险。这种分类对于有针对性的干预策略以及对个体进行基因检测的特征分析可能有用。

相似文献

1
Classification of childhood obesity using longitudinal clinical body mass index and its validation.利用纵向临床体重指数对儿童肥胖进行分类及其验证。
Int J Obes (Lond). 2025 Jul 17. doi: 10.1038/s41366-025-01836-z.
2
Classification of childhood obesity using longitudinal clinical body mass index and its validation.利用纵向临床体重指数对儿童肥胖进行分类及其验证
Res Sq. 2024 Dec 16:rs.3.rs-5392188. doi: 10.21203/rs.3.rs-5392188/v1.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Associations of Neighborhood Opportunity and Social Vulnerability With Trajectories of Childhood Body Mass Index and Obesity Among US Children.社区机会和社会脆弱性与美国儿童儿童期体重指数和肥胖轨迹的关联。
JAMA Netw Open. 2022 Dec 1;5(12):e2247957. doi: 10.1001/jamanetworkopen.2022.47957.
5
Interventions for preventing obesity in children.儿童肥胖预防干预措施。
Cochrane Database Syst Rev. 2019 Jul 23;7(7):CD001871. doi: 10.1002/14651858.CD001871.pub4.
6
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
7
Interventions to prevent obesity in children aged 5 to 11 years old.预防 5 至 11 岁儿童肥胖的干预措施。
Cochrane Database Syst Rev. 2024 May 20;5(5):CD015328. doi: 10.1002/14651858.CD015328.pub2.
8
What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A systematic review.在初级保健中使用药物治疗肥胖患者的临床效果和成本效益如何?系统评价。
Health Technol Assess. 2012;16(5):iii-xiv, 1-195. doi: 10.3310/hta16050.
9
[Association between obesity and the risk of microvascular complications in Yinzhou District, Ningbo adults with type 2 diabetes mellitus].[宁波鄞州区2型糖尿病成年患者肥胖与微血管并发症风险的相关性]
Wei Sheng Yan Jiu. 2025 Jul;54(4):608-620. doi: 10.19813/j.cnki.weishengyanjiu.2025.04.012.
10
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.

本文引用的文献

1
Setmelanotide in patients aged 2-5 years with rare MC4R pathway-associated obesity (VENTURE): a 1 year, open-label, multicenter, phase 3 trial.Setmelanotide用于2至5岁患有罕见的MC4R通路相关肥胖症患者的研究(VENTURE):一项为期1年的开放标签、多中心3期试验。
Lancet Diabetes Endocrinol. 2025 Jan;13(1):29-37. doi: 10.1016/S2213-8587(24)00273-0. Epub 2024 Nov 13.
2
Updates on Rare Genetic Variants, Genetic Testing, and Gene Therapy in Individuals With Obesity.肥胖个体中罕见基因变异、基因检测和基因治疗的最新进展。
Curr Obes Rep. 2024 Sep;13(3):626-641. doi: 10.1007/s13679-024-00567-y. Epub 2024 Jun 1.
3
Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity.
儿童和青少年肥胖评估与治疗临床实践指南
Pediatrics. 2023 Feb 1;151(2). doi: 10.1542/peds.2022-060640.
4
Association of Body Mass Index in Youth With Adult Cardiometabolic Risk.青少年的体重指数与成人心血管代谢风险的关联。
J Am Heart Assoc. 2020 Jul 21;9(14):e015288. doi: 10.1161/JAHA.119.015288. Epub 2020 Jul 4.
5
Child Excess Weight Status, Adult Excess Weight Status, and Cardiometabolic Risk Profile.儿童超重状况、成人超重状况与心血管代谢风险谱
Front Pediatr. 2020 Jun 9;8:301. doi: 10.3389/fped.2020.00301. eCollection 2020.
6
Not so implausible: impact of longitudinal assessment of implausible anthropometric measures on obesity prevalence and weight change in children and adolescents.并非如此难以置信:对不合理人体测量指标进行纵向评估对儿童和青少年肥胖患病率和体重变化的影响。
Ann Epidemiol. 2019 Mar;31:69-74.e5. doi: 10.1016/j.annepidem.2019.01.006. Epub 2019 Feb 5.
7
Patterns of body mass index milestones in early life and cardiometabolic risk in early adolescence.生命早期体重指数里程碑模式与青少年早期心血管代谢风险。
Int J Epidemiol. 2019 Feb 1;48(1):157-167. doi: 10.1093/ije/dyy286.
8
Acceleration of BMI in Early Childhood and Risk of Sustained Obesity.儿童早期 BMI 加速增长与持续肥胖风险增加有关。
N Engl J Med. 2018 Oct 4;379(14):1303-1312. doi: 10.1056/NEJMoa1803527.
9
Distinct child-to-adult body mass index trajectories are associated with different levels of adult cardiometabolic risk.儿童到成人的体重指数轨迹不同,与成人心血管代谢风险的不同水平相关。
Eur Heart J. 2018 Jun 21;39(24):2263-2270. doi: 10.1093/eurheartj/ehy161.
10
Impact of Severe Obesity on Cardiovascular Risk Factors in Youth.重度肥胖对青少年心血管危险因素的影响。
J Pediatr. 2018 Jan;192:105-114. doi: 10.1016/j.jpeds.2017.09.066.